```html

Non‑ulcer Dyspepsia: A Comprehensive Medical Guide

Overview

Non‑ulcer dyspepsia (NUD), also called functional dyspepsia, is a common disorder characterized by persistent or recurring upper‑abdominal discomfort or pain that cannot be explained by an ulcer, cancer, or another identifiable gastrointestinal disease. It belongs to the broader category of functional gastrointestinal disorders.

• Who it affects: Adults of any age, but most commonly individuals aged 30‑50 years. Women are slightly more likely than men to develop NUD.
• Prevalence: Worldwide, functional dyspepsia affects about 10‑20 % of the general population. In the United States, the prevalence is estimated at ~15 %, representing roughly 45 million adults.
• Impact: It is a leading cause of outpatient gastroenterology visits and accounts for up to 30 % of all referrals for upper‑GI endoscopy, despite most investigations returning normal.

Because the symptoms are often vague and overlap with other conditions (e.g., gastro‑oesophageal reflux disease, peptic ulcer disease), accurate diagnosis relies on a careful clinical evaluation and the exclusion of organic disease.

Symptoms

Symptoms must be present for at least three months, with an onset at least six months prior to diagnosis, according to the Rome IV criteria. The most common symptom clusters are:

1. Epigastric Pain or Burning

• Described as a dull, gnawing, or burning sensation in the upper abdomen.
• Often worsens after a meal or when the stomach is empty.

2. Early Satiety

• Feeling full after eating a small amount of food.
• Can lead to reduced calorie intake and unintended weight loss.

3. Post‑prandial Fullness

• Persistent sense of fullness during or after a meal that is disproportionate to the amount of food eaten.

4. Upper‑Abdominal Bloating

• Distension or a feeling of “tightness” in the stomach area.

5. Nausea and Occasionally Vomiting

• Usually mild; may be triggered by large meals or certain foods.

6. Associated Symptoms

• Heartburn or mild reflux‑type discomfort (but not classic GERD).
• Fatigue, anxiety, or depressive symptoms, reflecting the biopsychosocial nature of the disorder.

Symptoms are typically chronic, fluctuating, and may worsen with stress, caffeine, alcohol, or spicy foods.

Causes and Risk Factors

The exact cause of non‑ulcer dyspepsia remains unclear, but several mechanisms have been identified.

Pathophysiologic Contributors

• Impaired gastric accommodation: The stomach fails to relax properly after a meal, leading to early satiety and fullness.
• Delayed gastric emptying (gastroparesis): Food stays longer in the stomach, causing nausea and post‑prandial fullness.
• Visceral hypersensitivity: Heightened pain perception in the stomach and duodenum.
• Helicobacter pylori infection: May contribute in a subset of patients; eradication can improve symptoms in ~10‑20 % of cases (NIH, 2022).
• Psychological factors: Anxiety, depression, and stress can amplify symptom perception and affect gastric motility.
• Low‑grade inflammation: Emerging data suggest subtle immune activation in the duodenal mucosa of some patients.

Risk Factors

• Female sex (≈1.2‑1.5× higher risk)
• Age 30‑50 years
• Smoking and excessive alcohol consumption
• Caffeine‑rich diets
• Use of non‑steroidal anti‑inflammatory drugs (NSAIDs)
• History of anxiety or depressive disorders
• Positive H. pylori test (especially in regions with high prevalence)
• Family history of functional GI disorders

Diagnosis

Diagnosing NUD is a process of exclusion—ruling out structural, inflammatory, or metabolic causes of dyspepsia.

Step‑by‑Step Approach

1. Detailed History & Physical Exam: Characterize symptom pattern, red‑flag features (see “When to Seek Emergency Care”), medication use, and psychosocial context.
2. Laboratory Tests (optional, based on clinical suspicion):
   • Complete blood count (CBC) – to detect anemia.
   • Serum chemistry – to assess liver/kidney function.
   • H. pylori testing (urea breath test, stool antigen, or serology) if eradication therapy is being considered.
3. Upper Endoscopy (EGD):
   • Recommended for patients >55 years, those with alarm features, or when initial therapy fails.
   • Findings are normal in >80 % of NUD cases; the test primarily excludes ulcer, cancer, or erosive esophagitis.
4. Functional Tests (when needed):
   • Gastric emptying scintigraphy – assesses gastroparesis.
   • Balloon distension testing – evaluates visceral hypersensitivity (research setting).
   • Wireless motility capsule – non‑invasive measurement of gastric transit.
5. Application of Rome IV Criteria:
   • Symptoms of post‑prandial fullness, early satiety, epigastric pain/burning without an identifiable organic cause.

When all investigations are negative and criteria are met, a diagnosis of non‑ulcer dyspepsia is made.

Treatment Options

Treatment is individualized, often combining medication, lifestyle modification, and psychological support. The goal is symptom relief and improved quality of life.

1. Pharmacologic Therapies

• Proton‑pump inhibitors (PPIs) (e.g., omeprazole 20 mg daily):
  • Effective for epigastric pain/burning; up to 40 % of patients have symptom improvement.
• Histamine‑2 receptor antagonists (H2RAs) (e.g., ranitidine 150 mg BID):
  • Alternative for mild symptoms or patients intolerant to PPIs.
• Prokinetics (e.g., itopride, domperidone, low‑dose metoclopramide):
  • Enhance gastric emptying and improve early satiety; modest benefit noted in meta‑analyses.
• Low‑dose tricyclic antidepressants (TCAs) (e.g., amitriptyline 10‑25 mg at night):
  • Address visceral hypersensitivity and co‑existent mood disorders.
• Selective serotonin reuptake inhibitors (SSRIs) or serotonin‑noradrenaline reuptake inhibitors (SNRIs):
  • Useful when anxiety/depression is prominent; evidence for dyspepsia symptom relief is growing.
• Helicobacter pylori eradication therapy (triple or quadruple regimen):
  • Recommended in H. pylori‑positive patients; modest benefit (≈10 % absolute improvement).

2. Procedural Interventions

• Endoscopic gastric Botox injection: Investigational; may reduce antral contractility in refractory cases.
• Gastric electrical stimulation: Reserved for severe gastroparesis, not first‑line for NUD.

3. Lifestyle and Dietary Modifications

• Eat smaller, more frequent meals (5‑6 meals/day).
• Avoid known triggers: high‑fat foods, caffeine, carbonated drinks, alcohol, and very spicy meals.
• Chew food thoroughly; eat slowly and in a relaxed environment.
• Maintain a healthy weight; weight loss can worsen early satiety.
• Stop smoking and limit NSAID use; consider acetaminophen for pain.
• Stress‑reduction techniques (mindfulness, yoga, cognitive‑behavioral therapy) have demonstrated symptom benefit in randomized trials.

4. Psychological Therapies

• Cognitive‑behavioral therapy (CBT) – improves coping and reduces symptom severity.
• Gut‑directed hypnotherapy – effective in functional GI disorders.
• Psychiatric consultation for comorbid depression/anxiety.

Treatment is usually started with a PPI or H2RA for 4‑8 weeks; if symptoms persist, prokinetics or low‑dose TCAs are added. Ongoing reassessment every 2‑3 months helps tailor therapy.

Living with Non‑ulcer Dyspepsia

While the condition can be chronic, most people can achieve good control with the right strategies.

Daily Management Tips

• Meal Planning: Prepare low‑fat, low‑acid meals; use herbs (ginger, peppermint) known to aid digestion.
• Hydration: Sip water between meals rather than large volumes during eating to avoid gastric distension.
• Physical Activity: Light to moderate exercise (e.g., walking, cycling) after meals can stimulate gastric motility.
• Sleep Hygiene: Elevate the head of the bed 6‑10 cm if nighttime symptoms occur.
• Medication Adherence: Take PPIs 30 minutes before breakfast; do not discontinue abruptly without physician guidance.
• Symptom Diary: Record foods, stressors, and symptom severity; share with your provider to identify patterns.
• Support Networks: Join patient forums or local support groups to exchange coping strategies.

Prevention

Because NUD often arises from a mix of physiological and lifestyle factors, prevention focuses on modifiable risks.

• Limit intake of fatty, fried, and highly spiced foods.
• Avoid excess caffeine and alcohol.
• Quit smoking; nicotine interferes with gastric mucosal protection.
• Use NSAIDs sparingly; if needed, co‑prescribe a PPI.
• Manage stress through regular relaxation practices.
• Screen for and treat H. pylori infection when appropriate.
• Maintain a healthy BMI (18.5‑24.9 kg/m²).

Complications

Non‑ulcer dyspepsia itself is not life‑threatening, but untreated or poorly managed disease can lead to several issues:

• Nutritional deficiencies due to early satiety and reduced intake.
• Weight loss or malnutrition in severe cases.
• Impaired quality of life: chronic pain and anxiety can affect work productivity and mental health.
• Increased health‑care utilization and costs (average US cost ≈ $2,300 per patient per year – Cleveland Clinic, 2021).
• Potential progression to functional gastroparesis if motility disturbance worsens.

When to Seek Emergency Care

---

Sources: Mayo Clinic, WHO, CDC, NIH, Cleveland Clinic, Rome IV Consensus (2022), NCBI.

```